Comment on CMS-2026-1255-0001
ViiV HealthcareSupportBusiness
Summary: ViiV Healthcare supports the proposed rule to enhance the efficiency and accountability of utilization management processes, particularly regarding electronic prior authorization standards. The company advocates for stronger protections for HIV treatments and PrEP, including prohibiting prior authorization for stable patients and ensuring timely access to prevention services.
“Please find attached ViiV Healthcare’s comments on the Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges proposed rule [CMS-0062-P]. Thank you for considering our input.